Kelly James
Surgery · Independence, MONPI 1366428302
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 91.1% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2024 at $34,313 and has fallen 59.5% since, to $13,892 in 2025. Among surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 306 payments — averaging $345.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$96K
- Aroa Biosurgery Incorporated$5K
- Senseonics, Incorporated$1K
- Organogenesis Inc.$988
- Integra Lifesciences Corporation$531
- Acera Surgical, Inc.$345
- plus $1K from 22 others
Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Convatec Inc.$5K
What the payments were for
- Consulting fees$33,48432%
- Speaking & faculty fees$47,73445%
- Travel & lodging$16,67216%
- Food & beverage$7,8167%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 204 | $96,268 |
| Aroa Biosurgery Incorporated | 7 | $5,123 |
| Senseonics, Incorporated | 3 | $1,200 |
| Organogenesis Inc. | 28 | $988 |
| Integra Lifesciences Corporation | 18 | $531 |
| Acera Surgical, Inc. | 13 | $345 |
| Ascensia Diabetes Care US Inc. | 1 | $240 |
| Convatec Inc. | 1 | $198 |
| Kerecis Limited | 4 | $158 |
| Stryker | 1 | $114 |
| Polynovo North America LLC | 3 | $85 |
| Z-medica, LLC | 2 | $63 |
| Davol Inc. | 2 | $41 |
| Medline Industries LP | 1 | $36 |
| Melinta Therapeutics, LLC | 2 | $36 |
| Mimedx Group, Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $30 |
| Merck | 2 | $30 |
| Vertex | 1 | $28 |
| Bioventus LLC | 1 | $26 |
| AbbVie | 1 | $24 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $17 |
| 3M Company | 1 | $17 |
| Lifenet Health | 1 | $16 |
| TEI Medical Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Acell, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PICO$41,411
- Oasis$28,087
- PICO Single Use Negative Pressure Wound Therapy$18,564
- Grafix$16,464
- GRAFIX PL$15,321
- Grafix XC$15,085
- ACTICOAT 4" X 4"$9,909
- NA$9,694
- COLLAGENASE SANTYL$7,708
- ALLEVYN LIFE L 15.4X15.4 CTN10$7,013
- OASIS MICRO$5,813
- PICO 7$3,603
- PICO 14$3,000
- RENASYS TOUCH$2,829
- Eversense$1,200
- Iodosorb Ointment 40g USA$748
- Biobrane$413
- Stravix$340
- EVERSENSE E3 SENSOR KIT - RETAIL$240
- InnovaMatrix AC$198
How this compares
$105,707 in reported general payments places this provider in the 95th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 11 | $9,564 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $238 |
| Ciprofloxacin Hcl | 14 | $116 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $96,268 | $9,56411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 612 surgery providers in Missouri.
Other surgery in Independence
- James ScottSaint Louis$307K
- Omar GuerraSaint Louis$249K
- John TannColumbia$216K
- Mark DrakeSaint Louis$212K
- Adeel KhanSaint Louis$204K
- Michael AwadSaint Louis$176K
- Patricia HodginsFenton$145K
- Laurie PunchSaint Louis$141K
- Jeffrey BlatnikSaint Louis$134K
- Bradley MooreKansas City$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.